A new study found that eye contact can make us act more honestly.
TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the third quarter 2018.
Geologists have discovered that a set of 28 footprints left behind by a reptile-like creature 310 million years ago are the oldest ever to be found in Grand Canyon National Park.
Facebook, Snapchat, and Instagram may not be great for personal well-being. The first experimental study examining use of multiple platforms shows a causal link between time spent on these social media and increased depression and loneliness.
Humans think using their brain’s navigation system: Researchers combine individual threads of evidence to form a theory of human thinking.
A new study focuses on hydrodynamic effects of external disturbances on fluids at critical points, including inconsistent turbulence in all directions, or anisotropy, and varying degrees of compressibility.
The effectiveness of nanopore biosensors capable of identifying sugar chains from biological molecules involved in key biological processes also depends on the nanopore’s electrical charge and inner pore design.
AbbVie has signed on to be the first tenant at a new biotech campus in south San Francisco, inking a long-term lease for 479,000 square feet in a planned 12-story building.
AstraZeneca has decided to discontinue one of its midstage cancer drugs—mTOR inhibitor vistusertib—despite reporting encouraging clinical data earlier in the year.
In the wake of a Complete Response Letter issued by the FDA, Trevana, Inc. is slashing one-third of its workforce. On Wednesday, Merrimack Pharmaceuticals also announced it was terminating 60 percent of its staff as the company narrows its research and development focus.